Wellington Management Group
CAPR icon

Wellington Management Group’s Capricor Therapeutics CAPR Stock Holding History

Wellington Management Group’s Portfolio CAPR Stock Details CAPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.3M Sell
108,604
-19,666
-15% -$524K ﹤0.01% 1469
2025
Q4 		$3.7M Sell
128,270
-4,045
-3% -$52.8K ﹤0.01% 1472
2025
Q3 		$954K Buy
132,315
+438
+0.3% +$3.23K ﹤0.01% 1787
2025
Q2 		$1.31M Buy
131,877
+21,146
+19% +$223K ﹤0.01% 1674
2025
Q1 		$1.05M Buy
110,731
+69,772
+170% +$968K ﹤0.01% 1697
2024
Q4 		$565K Buy
+40,959
New +$718K ﹤0.01% 1815
2024
Q2 		– Sell
-79,759
Closed -$542K – 1891
2024
Q1 		$542K Buy
+79,759
New +$386K ﹤0.01% 1800

Other funds holding CAPR

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JHC
Jones Hill Capital New York $466M AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Wellington Management Group's CAPR Position: Q1 2026 in Review

Wellington Management Group reduced its Capricor Therapeutics (CAPR) stake by 15% in Q1 2026, selling an estimated $524K and leaving 108,604 shares worth $3.3M. The position accounts for ﹤0.01% of the portfolio, ranked #1469.

Wellington Management Group first reported a position in CAPR in Q1 2024 and has held it in 7 quarters since. The position peaked at $3.7M in Q4 2025. 177 funds tracked by Wall St. Rank hold CAPR as of Q1 2026.

  • Wellington Management Group held 108,604 shares of Capricor Therapeutics worth $3.3M as of Q1 2026.
  • Wellington Management Group sold 19,666 Capricor Therapeutics shares in Q1 2026, an estimated $524K.
  • Capricor Therapeutics made up ﹤0.01% of Wellington Management Group's portfolio in Q1 2026, its #1469 holding.
  • Wellington Management Group first reported a position in Capricor Therapeutics in Q1 2024 and has held it in 7 quarters since.
  • Wellington Management Group's Capricor Therapeutics position peaked at $3.7M in Q4 2025.
  • 177 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q1 2026.

Based on Wellington Management Group's 13F filing for Q1 2026, filed 15 May 2026.